Join the Moderna Therapeutics mailing list.
Harvard Business School, January 31, 2014: Body, Heal Thyself: Stéphane Bancel has taken Moderna Therapeutics from a one-man shop to a company that's poised to revolutionize the biotech world
Xconomy, January 14, 2014: Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido
Genetic Engineering & Biotechnology News, January 14, 2014: Flush with Cash, Moderna Launches New Oncology-Focused Venture
Xconomy, January 13, 2014: Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion
Genetic Engineering & Biotechnology News, January 13, 2014: Alexion, Moderna to Develop Rare Disease-Fighting mRNA Therapeutics
Boston.com, January 13, 2014: Alexion, Moderna Announce Agreement to Develop Messenger RNA Therapeutics
BusinessWire, November 21, 2013: Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors
Dow Jones, November 20, 2013: Staying Private, Moderna Raises $110M for Messenger RNA Therapeutics
Xconomy, November 20, 2013: Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs
FierceBiotech, November 20, 2013: Moderna nails $110M to get mRNA tech into the clinic
Xconomy, October 2, 2013: Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs
FierceBiotech, September 24, 2013: Moderna Therapeutics Wins Fierce 15 Biotech Award
Bloomberg, March 28, 2013: AstraZeneca CEO Chases Multiple Strands in RNA Drug Quest
Xconomy, March 21, 2013: AstraZeneca Shells Out $240 Upfront For Moderna mRNA Drugs
New York Times, March 21, 2013: AstraZeneca to Pay $240 Million to Moderna Therapeutics
Boston Magazine, February 26, 2013: Does Moderna Therapeutics Have the Next Big Thing in Biotech?
Xconomy, December 6, 2012: Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug”
February 19, 2014: Massachusetts Life Sciences Center Awards Tax Incentives to 33 Companies Center Awards $25 million to foster job growth in the Massachusetts Life Sciences sectors
December 17, 2013: Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors
September 24, 2013: Moderna Therapeutics Named a “Fierce 15” Biotech Company for 2013.
April 30, 2013: Henri A. Termeer Joins Moderna Therapeutics Board of Directors
February 27, 2013: Massachusetts Life Sciences Center Awards Tax Incentives to 25 Companies
February 22, 2012: Massachusetts Life Sciences Center Announces Tax Incentives Targeting Growth at 28 Companies Center Awards $21.2 million to foster job growth in the Massachusetts Life Sciences sectors